Close

White Papers

New back pain clinical trial

PharmaLinea's >Your< Back Pain Capsules clinically shown to substantially improve standard physical therapy's effect on back pain severity and mobility PharmaLinea has announced the publication of another clinical study on their finished products, addressing a leading cause of disability worldwide...

Made Smarter and tech institutes join forces to demystify digital transformation

‘Made Smarter technologies: powering the digital transformation of SME manufacturers’ is a practical guide from the government-backed and industry-led technology adoption programme in the North West. The free-to-download document aims to inform and inspire manufacturers exploring existing technologies such as...

Why Tissue Paper Is The Smart Choice For A Sustainable World

COMMITTED TO SUSTAINABILITY ACROSS THE SUPPLY CHAIN ETS is committed to driving sustainable practices throughout the industry. It is also looking to increase sustainability across the supply chain– from water and energy through to transport and recovery. Tissue paper production...

From metrics to impact: Selecting the right measures to determine MSL value

The role of Medical Science Liaisons (MSLs) has undergone a remarkable transformation. No longer confined to disseminating scientific information to a select group of Key Opinion Leaders (KOLs), MSLs now find themselves at the forefront of engaging a diverse...

Unlocking the clinical trial potential of Africa

Africa is facing a pivotal moment in its role in clinical trial history. With ongoing improvements around infrastructure, continued investment, as well as being home to one of the world’s largest working age populations, the region is finally being...

Addressing the complex demands of cell line development

The global biologics market is growing. Valued at $461.74 billion in 2022, the market value is forecast to increase at a compound annual growth rate of 10.3% from 2023 to 20301. This is due to the promise biologics have...

Ensuring Everything is A-OK at AKBA

The roots of the Asahi Kasei Corporation stretch back to 1931 when it was founded in Tokyo, Japan, as a supplier of industrial chemicals, most notably ammonia and nitric acid. Over the years, the company has expanded its reach...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read